HLS Therapeutics Crecimiento futuro
Future controles de criterios 0/6
Se prevé un crecimiento anual de los beneficios y los ingresos de HLS Therapeutics de 33.8% y 5.3% respectivamente, mientras que el BPA crecerá en un 37.3% al año.
Información clave
33.8%
Tasa de crecimiento de los beneficios
37.3%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 56.8% |
Tasa de crecimiento de los ingresos | 5.3% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | 15 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar
Apr 14Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Apr 06Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be
Nov 16Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Sep 13Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?
May 05HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Apr 05HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05
Mar 20HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05
Nov 30Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term
Nov 11We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt
Sep 14HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Aug 15HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05
Jul 14HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05
Jun 23HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
Jun 08HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
May 25HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05
May 10Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook
Apr 30HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05
Apr 15HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05
Mar 26HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates
Mar 22HLS Therapeutics (TSE:HLS) Will Pay A Dividend Of CA$0.05
Nov 29HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05
Aug 10Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt
Apr 30Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 86 | -9 | 32 | 34 | 1 |
12/31/2025 | 73 | -18 | 26 | 28 | 3 |
12/31/2024 | 64 | -21 | 9 | 9 | 4 |
12/31/2023 | 63 | -28 | 16 | 16 | N/A |
9/30/2023 | 63 | -29 | 15 | 16 | N/A |
6/30/2023 | 63 | -26 | 4 | 14 | N/A |
3/31/2023 | 62 | -26 | 5 | 15 | N/A |
12/31/2022 | 61 | -24 | 7 | 17 | N/A |
9/30/2022 | 61 | -21 | 7 | 17 | N/A |
6/30/2022 | 61 | -19 | 16 | 17 | N/A |
3/31/2022 | 60 | -12 | 12 | 15 | N/A |
12/31/2021 | 60 | -13 | 12 | 16 | N/A |
9/30/2021 | 61 | -16 | 11 | 18 | N/A |
6/30/2021 | 59 | -16 | -22 | 17 | N/A |
3/31/2021 | 57 | -20 | -28 | 11 | N/A |
12/31/2020 | 56 | -15 | -35 | 9 | N/A |
9/30/2020 | 54 | -20 | -41 | 6 | N/A |
6/30/2020 | 54 | -21 | -9 | 10 | N/A |
3/31/2020 | 55 | -16 | 4 | 23 | N/A |
12/31/2019 | 54 | -20 | 11 | 26 | N/A |
9/30/2019 | 57 | -7 | 11 | 35 | N/A |
6/30/2019 | 59 | -25 | 22 | 35 | N/A |
3/31/2019 | 61 | -24 | 14 | 28 | N/A |
12/31/2018 | 61 | -25 | 18 | 33 | N/A |
9/30/2018 | 65 | -26 | 28 | 30 | N/A |
6/30/2018 | 70 | -8 | 20 | 33 | N/A |
3/31/2018 | 73 | -8 | 24 | 37 | N/A |
12/31/2017 | 75 | -6 | 17 | 27 | N/A |
9/30/2017 | 71 | -11 | N/A | 25 | N/A |
12/31/2016 | 54 | -15 | N/A | 22 | N/A |
12/31/2015 | 20 | -10 | N/A | -6 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que HLS siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que HLS siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que HLS siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (5.3% al año) de HLS crezcan más despacio que el mercado de Canadian (6.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.3% al año) de HLS crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de HLS se prevé que sea elevada dentro de 3 años.